Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lipotec is a global leader in the research, development, and manufacture of active ingredients for the cosmetic and personal care industries. Founded in 1987 and headquartered in Barcelona, Spain, the company specializes in three core technology platforms: peptide synthesis, biotechnology, and advanced delivery systems. Lipotec is widely recognized for its "Molecular Cosmetics" approach, which focuses on high-efficacy peptides that target specific biological pathways to address skin aging, hydration, and protection. In 2012, the company was acquired by Lubrizol and now operates as a key component of the Lubrizol Life Science - Beauty division. Its portfolio includes iconic ingredients such as Argireline, the first peptide for expression wrinkles, and Eyeseryl, which are used by major global beauty brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lipotec Group.